Search

Your search keyword '"Story, Jennifer"' showing total 113 results

Search Constraints

Start Over You searched for: Author "Story, Jennifer" Remove constraint Author: "Story, Jennifer"
113 results on '"Story, Jennifer"'

Search Results

1. Reopening Washington Schools 2020: Special Education Guidance. Updated

2. Special Education Reopening Guidance: Least Restrictive Environment (LRE) Case Studies

3. Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial

4. Assessment as Inquiry: Learning the Hypothesis-Test Process.

5. A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells

8. Phase I Study of Ixazomib with Conventional Chemotherapy in the Treatment of Acute Myeloid Leukemia in Older Adults

11. A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies

12. Ixazomib in addition to chemotherapy for the treatment of acute lymphoblastic leukemia in older adults

13. Finding Students before They Find Me: HT in the Classroom.

15. When Assessment Is Inquiry

16. Additional file 1 of A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells

17. Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity

18. Phase I Study of Ixazomib Added to Chemotherapy in the Treatment of Acute Lymphoblastic Leukemia in Older Adults

19. Outcomes of Therapy with Venetoclax Combined with Hypomethylating Agents in Favorable-Risk Acute Myeloid Leukemia (AML)

20. Phase I Study of Ixazomib with Conventional Chemotherapy in the Treatment of Acute Myeloid Leukemia in Older Adults

21. A Phase 1 Trial of Regorafenib in Advanced Myeloid Malignancies

23. A phase 1 study of the antibody‐drug conjugate brentuximab vedotin with re‐induction chemotherapy in patients with CD30‐expressing relapsed/refractory acute myeloid leukemia

25. Pregnancy Outcomes, Risk Factors, and Gestational Cell Count Trends in Pregnant Women with Essential Thrombocythemia and Polycythemia Vera

26. A specialized post‐transcriptional program in chemoresistant, quiescent cancer cells

27. Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity

28. Phase II Clinical Trial of Alisertib, an Aurora a Kinase Inhibitor, in Combination with Induction Chemotherapy in High-Risk, Untreated Patients with Acute Myeloid Leukemia

29. Phase I Study of the Antibody-Drug Conjugate Brentuximab Vedotin Combined with Re-Induction Chemotherapy in Patients with CD30-Expressing Relapsed/Refractory Acute Myeloid Leukemia

30. Single-Cell RNA-Seq Reveals AML Cellular Hierarchies Relevant to Clinical Outcomes and Immunity

31. Phase I Study of Ixazomib in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults

32. Phase I Study of Ixazomib in Addition to Chemotherapy for the Treatment of Acute Myeloid Leukemia in Older Adults

33. A post-transcriptional program of chemoresistance by AU-rich elements and TTP

34. Single-Cell Analysis of AML Reveals Determinants of Disease Progression and Immune Evasion

40. Single-Cell Multiomics Analysis Reveals Potential Drivers of Response to the Anti-TIM3 Inhibitor Sabatolimab Combined with Azacitidine in MDS and CMML

41. Multi-shot PROPELLER for high-field preclinical MRI

43. Cellular and in Vivo Activity of JNJ-28871063, A Nonquinazoline Pan-ErbB Kinase Inhibitor That Crosses the Blood-Brain Barrier and Displays Efficacy against Intracranial Tumors

44. Cellular and in Vivo Activity of JNJ-28871063, A Nonquinazoline Pan-ErbB Kinase Inhibitor That Crosses the Blood-Brain Barrier and Displays Efficacy against Intracranial Tumors

45. Additional file 5 of A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells

46. Additional file 4 of A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells

47. Additional file 4 of A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells

48. Additional file 5 of A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells

49. Instead of bemoaning taxes, focus on what we get from them.

50. Field of genes: some of the world's worst polluters are fixing dinner.

Catalog

Books, media, physical & digital resources